| Financial Year |
March 31 2023 |
| Monetary Funds |
509,145,987.70 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
32,334,474.68 |
| Accounts Receivable |
774,488,225.99 |
| Advances to Suppliers |
53,423,504.05 |
| Other Receivables |
6,602,293.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
209,507,335.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,098,641.94 |
| Total Current Assets |
1,764,601,174.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
673,980,506.93 |
| Under-construction Projects |
49,984,654.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
120,317,703.47 |
| R&D expenses |
-- |
| Goodwill |
31,613,337.40 |
| Long-Term Deferred and Prepaid Expenses |
3,946,282.60 |
| Deferred Income Tax Assets |
14,193,192.90 |
| Other Non-Current Assets |
8,836,879.21 |
| Sub-Total of Non-Current Assets |
993,836,576.11 |
| Total Assets |
2,758,437,750.50 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
151,407,669.66 |
| Accounts Payable |
439,177,839.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
29,780,929.92 |
| Taxes Payable |
7,026,155.92 |
| Interest Payable |
2,111,333.39 |
| Dividend Payable |
-- |
| Other payables |
54,410,897.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,705,220.31 |
| Other Current Liabilities |
11,177,800.37 |
| Sub-Total of Current Liabilities |
806,637,540.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
43,582,534.84 |
| Total Liabilities |
850,220,075.19 |
| Paid-In Capital(Or Share Stock) |
1,108,301,357.00 |
| Capital Surplus |
879,999,985.33 |
| Surplus Reserve |
71,015,072.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-189,910,902.98 |
| Minority Stockholder's Interest |
38,765,763.54 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,869,451,911.77 |
| Owner's Equity（Stockholder's Equity） |
1,908,217,675.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,758,437,750.50 |
